Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvimopan for GI recovery after CRS and HIPEC
NCT03352414Phase 2Terminated
- Sponsor
- University of California, San Diego
- Start
- Mar 2018
- Primary completion
- Apr 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ileus comparing Alvimopan Arm with Placebo Arm (2 arms). Primary endpoint: Time to Return of Upper and Lower GI Function up to 2 weeks. Started Mar 2018; status: terminated.
02
Drugs
alvimopan
03
Conditions
ileus
Beyond the preview
Go deeper on NCT03352414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03352414.